Effective immediately, South Shore Health (South Shore Hospital, South Shore Medical Center, and Health Express) will only conduct COVID-19 tests on patients requiring admission to the hospital or are at high risk and for healthcare workers that are in contact with a positive patient and become...

South Shore Medical Center will now contact patients directly if their appointment is affected by inclement weather.

South Shore Health continues to actively monitor the COVID-19 situation.

Several weeks after launching an initial mobile integrated health (MIH) program in Weymouth, South Shore Health has partnered with the town of Hanover to expand the program.

Callers may experience delays and issues reaching our locations by phone. Our team is working to resolve these issues, and we appreciate your patience and understanding.

The purpose of the project is to create and maintain a national resource documenting and studying neurological complications of coronavirus disease, the illness caused by infection with the SARS-CoV-2 novel coronavirus.

The new GE Ascend CT scanner, the second of its kind in the U.S., uses artificial intelligence and is designed to improve workflow and patient comfort, while providing superior image quality.

Vaccines remain one of the most effective ways to protect children and communities from serious illness. Therefore, despite recent changes announced by the CDC, South Shore Medical Center's vaccine recommendations remain the same and continue to follow the scientific-based guidance of the American Academy of Pediatrics. With that in mind, our vaccine recommendations will not change and will continue to follow the scientific evidence and guidance of the American Academy of Pediatrics (AAP).

Blue Cross Blue Shield of Massachusetts has selected South Shore Health’s NeuroSpine Center as a Blue Distinction Center+ for Spine Surgery, as part of the Blue Distinction Specialty Care program. Blue Distinction Centers ® are nationally designated healthcare facilities that show a commitment to...

With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.